According to Insmed's latest financial reports the company's current EPS (TTM) is -$8.46. In 2022 the company made an earnings per share (EPS) of -$6.26 a decrease over its 2021 EPS that were of -$6.21.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$7.94 | 26.81% |
2022 | -$6.26 | 0.78% |
2021 | -$6.21 | 28.57% |
2020 | -$4.83 | -0.99% |
2019 | -$4.88 | -27.96% |
2018 | -$6.77 | 47.55% |
2017 | -$4.59 | 0.7% |
2016 | -$4.56 | 39.9% |
2015 | -$3.26 | 9.73% |
2014 | -$2.97 | 17.09% |
2013 | -$2.54 | 0.64% |
2012 | -$2.52 | -46.42% |
2011 | -$4.70 | 497.96% |
2010 | -$0.79 | -105.1% |
2009 | $15.42 | -850.78% |
2008 | -$2.05 | -24.71% |
2007 | -$2.73 | -71.67% |
2006 | -$9.63 | -28.57% |
2005 | -$13.48 | 23.53% |
2004 | -$10.91 | 134.48% |
2003 | -$4.65 | -73.64% |
2002 | -$17.65 | -2.65% |
2001 | -$18.13 | -86.64% |
2000 | -$135.76 |